A drug pipeline is the set of drug candidates that a pharmaceutical company has under discovery or development at any given point in time. This involves ...
Therapeutic Area. Product Name. Indication Sought. U.S. Development Stage. E.U. Development Stage. Cardiovascular and. XARELTO® (rivaroxaban).
Jan 14, 2013 ... When analysts review a big pharma's future prospects, they rightly focus on those drugs that are in the last stage of clinical trials (phase 3).
Discover why we're experiencing a rich pipeline of drug development and explore ... efforts in drug discovery & innovation. http://t.co/lNDCK0oVtp #pharma.
Nov 6, 2013 ... In Big Pharma, you're only as good as your pipeline, your product lineup and how you shape up relative to the threat of a looming loss of patent ...
Reach active buyers and immediately increase your visibilityGet Started
Dec 30, 2013 ... Matt Coffina: For Morningstar StockInvestor, I am Matt Coffina. I'm joined today by Damien Conover, who is the director of our health-care team, ...
Pharma market of finished dosage forms, active pharmaceutical ingredients, marketing ... pipelinepharma ... The largest pharmaceutical products marketplace .
May 5, 2014 ... The pharmaceutical industry is undergoing a rapid transformation. Here are some of the biggest drug trends in Big Pharma's pipeline.
Our Medicines in Development. Pfizer is prioritizing its research and development efforts in areas with the greatest scientific and commercial promise: ...
Pharmaceuticals · Pipeline · Areas of Focus · Major R&D Facilities ... Pipeline Information (as of June 30, 2014) (PDF:109KB). Go back to the top of this page ...
In the pharmaceuticals sector, a drugs pipeline consists of the drugs that a company has under development or is testing. This includes completely new drugs, ...
Pipeline. Developing promising new therapies for patients with rare genetic diseases. ... The company has a growing product pipeline, with multiple clinical and preclinical ... Copyright 2014 BioMarin Pharmaceutical Inc. All Rights Reserved.
The pharmaceutical industry is extremely competitive, and drug companies are under tremendous pressure to generate revenue by developing drugs that will demonstrate a high profitability. Pharmaceutical pipelines are the set of drugs that each company is currently working on. A pipeline consists of drugs that have already been released to the market, but for which they are researching new methods of use, new variations of existing drugs, and new drugs currently being formulated and tested.
The development of a new drug can cost millions of dollars, so drug companies won't take on the task of manufacturing a drug if they are not convinced that there will be a large financial payoff. Often, competing pharmaceutical companies will be working on the same type of drug, and will offer payoffs and profit sharing to another company that has advanced further in the research or has already conducted trials on the drug.
The pharmaceutical pipeline is a strong indicator of future growth and profit, and the market value of a pharmaceutical company is partly based upon the drugs they are developing at any given time. Companies usually have a number of drugs in their pipeline, but are dependent upon only one or two of them to generate a considerable monetary windfall.
Be sure to reference Business.com for additional information and links on pharmaceutical pipelines.
Receive tips, tools, and case studies with the Business.com Advisor, our weekly email newsletter
Thanks for subscribing! To ensure you receive your weekly newsletter, please add firstname.lastname@example.org to your safe sender list.
Briefly describe your project and get matched with the top vendors!